Growth Metrics

Neuphoria Therapeutics (NEUP) EPS (Basic) (2023 - 2026)

Neuphoria Therapeutics (NEUP) reported EPS (Basic) of -$0.09 for Q1 2026, down 101.37% year-over-year from $6.55 in Q1 2025, and down 121.95% on a QoQ basis from $0.41 in Q4 2025.

Neuphoria Therapeutics (NEUP) has 4 years of EPS (Basic) data on file, last reported at -$0.09 in Q1 2026.

  • Quarterly EPS (Basic) fell 101.37% year-over-year to -$0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.88 (down 871.88% YoY) and the FY2025 annual result came in at -$0.23, up 98.76% from the prior year.
  • EPS (Basic) declined to -$0.09 in Q1 2026 per NEUP's latest filing, from $0.41 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.55 in Q1 2025 and bottomed at -$5.79 in Q2 2025.
  • The 4-year median for EPS (Basic) is -$1.23 (2024), against an average of -$1.52.
  • The widest annual swing landed in 2024, when EPS (Basic) slumped 16848.48%; it then jumped 331.45% in 2025.
  • Tracing NEUP's EPS (Basic) over 4 years: stood at -$5.31 in 2023, then jumped by 76.84% to -$1.23 in 2024, then soared by 133.33% to $0.41 in 2025, then sank by 121.95% to -$0.09 in 2026.
  • Per Business Quant, the three latest NEUP EPS (Basic) figures stand at -$0.09 (Q1 2026), $0.41 (Q4 2025), and -$4.41 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Neuphoria Therapeutics 28.35 Mn 8.95 Mn - -0.09

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.09
Dec 31, 2025 0.41
Sep 30, 2025 -4.41
Jun 30, 2025 -5.79
Mar 31, 2025 6.55
Dec 31, 2024 -1.23
Sep 30, 2024 -0.62
Jun 30, 2024 -3.42
Mar 31, 2024 -2.83
Dec 31, 2023 -5.31
Sep 30, 2023 0.00